parthenolide has been researched along with osteoprotegerin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, HT; Joyce, DA; Steer, JH; Xu, J; Yip, KH; Zheng, MH | 1 |
1 other study(ies) available for parthenolide and osteoprotegerin
| Article | Year |
|---|---|
Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Bone and Bones; Bone Resorption; Cell Differentiation; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation; Genes, Reporter; Glycoproteins; Green Fluorescent Proteins; Interleukin-1; Lactones; Lipopolysaccharides; Luciferases; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Confocal; NF-kappa B; Osteoclasts; Osteolysis; Osteoprotegerin; Protein Transport; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Time Factors; TNF Receptor-Associated Factor 6; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2004 |